In an AngII‐induced mouse model of pathological cardiac hypertrophy, the pan‐HDAC inhibitor (HDACI) emodin ameliorates hypertrophy by inhibiting the activity of class I, IIa, and IIb HDACs.392. This evidence concerns the gene HDAC9 and cardiac hypertrophy.